FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis FACTS I: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active ...
FACTS I: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of the Efficacy and Safety of OPC-6535 Tablets in the Treatment of Subjects With Active Ulcerative Colitis FACTS I: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of ...
Ulcerative Colitis
Drug: OPC-6535 Tablets (drug)
Otsuka Pharmaceutical Development & Commercialization, Inc.
FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Active Ulcerative Colitis FACTS II: A Study to Test the Safety and Effectiveness of a New Medication on the Treatment of Activ ...
FACTS II: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study of the Efficacy and Safety of OPC-6535 Tablets in the Treatment of Subjects With Active Ulcerative Colitis FACTS II: A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Study o ...
Ulcerative Colitis
Drug: OPC-6535 Tablets (drug)
Otsuka Pharmaceutical Development & Commercialization, Inc.